Irene Muñoz-Gallego

Dr. Irene Muñoz-Gallego


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
EVEsther Viedma
Esther Viedma
DPDafne Pérez-Montarelo
Dafne Pérez-Montarelo
JVJennifer Villa
Jennifer Villa
IMIrene Muñoz-Gallego
Irene Muñoz-Gallego
NLNieves Larrosa
Nieves Larrosa
FCFernando Chaves
Fernando Chaves
The ability of Staphylococcus aureus to invade tissues and cause an infectious disease is the result of a multi-factorial process supported by the huge number of virulence factors inherent to this microorganism tightly regulated by the accessory gene regulator (agr). During antimicrobial therapy bacteria may be exposed to sub-inhibitory concentrations (subMICs) of antibiotics that may trigger transcriptional changes that may have an impact on the pathogenesis of infection. The objective of this study was to investigate the effect of oxacillin sub-MICs on agr system expression as the key component in the regulation of virulence in methicillin-susceptible (MSSA) and -resistant S. aureus (MRSA) strains. Furthermore, we studied the genetic basis of the agr locus and their potential association with the expression levels. We have examined the expression of RNAIII and agrA mRNA as biomarkers for agr expression in the presence and absence of oxacillin subMICs in 10 MSSA and 4 MRSA clinical strains belonging to 5 clonal complexes (CC45-agrI, CC8-agrI, CC5-agrII, CC15-agrII and CC30-agrIII) causing endovascular complications. The DNA sequences of agr locus were obtained by whole genome sequencing. Our results revealed that exposure to subMICs of oxacillin had an impact on agr locus expression modifying the relative levels of expression with increases in 11 strains and with decreases in 3 strains. Thereby, the exposure to subMICs of oxacillin resulted in higher levels of expression of agr in CC15 and CC45 and lower levels in CC30. We also observed the presence of mutations in agrC and agrA in 13/14 strains with similar mutation profiles among strains within individual CCs except for strains of CC5. Although, agr expression levels differed among strains within CCs, the presence of these mutations was associated with differences in agr expression levels in most cases. Changes in agr expression induced by exposure to oxacillin subMICs should be considered because they could lead to changes in the virulence modulation and have an adverse effect on the course of infection, especially in certain clonal complexes.

13 August 2020 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
IMIrene Muñoz-Gallego
Irene Muñoz-Gallego
EVEsther Viedma
Esther Viedma
Jaime EstebanJaime Esteban
Jaime Esteban
MMMikel Mancheño-Losa
Mikel Mancheño-Losa
JGJoaquín García-Cañete
Joaquín García-Cañete
GCGloria Pérez Caballero
Gloria Pérez Caballero
Staphylococcus aureus is the leading cause of prosthetic joint infection (PJI). Beyond the antibiogram, little attention has been given to the influence of deep microbiological characteristics on patient’s prognosis. Our aim was to investigate whether microbiological genotypic and phenotypic features have a significant influence on infection pathogenesis and patient outcome. prospective multicentre study was performed, including all S. aureus PJIs (2016-2017). Clinical data, phenotypic (agr functionality, β-hemolysis, biofilm formation) and genotypic characteristics of the strains were collected. Biofilm susceptibility to antimicrobials was investigated (MBEC assay). 88 patients (39.8% men, age 74.7±14.1 years) were included. Forty-five had early post-operative (EPI), 21 chronic (CPI), and 19 hematogenous infections (HI). Twenty (22.7%) were caused by MRSA. High genotypic diversity was observed, including 16 clonal complexes (CC), CC5 being the most frequent (30.7%). agr activity was greater in EPI than CPI (55.6% vs 28.6%, p=0.041). Strains causing EPI were phenotypically and genotypically similar, regardless of symptom duration. Treatment failure (36.5%) occurred less frequently among cases treated with implant removal. In cases treated with debridement and implant retention, there were fewer failures among those who received combination therapy with rifampin. No genotypic or phenotypic characteristics predicted failure, except vancomycin MIC>=1.5 mg/L (23.1% failure vs 3.4%, p=0.044). MBEC50 was >128 mg/L for all antibiotics tested and showed no association with prognosis. S. aureus with different genotypic backgrounds is capable of causing PJI, showing slight differences in clinical presentation and pathogenesis. No major microbiological characteristics were observed to influence the outcome, including MBEC.

18 April 2021 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
IMIrene Muñoz-Gallego
Irene Muñoz-Gallego
NDNerea Díaz‐Madridano
Nerea Díaz‐Madridano
NMNoelia Moral
Noelia Moral
CPConsuelo Pascual
Consuelo Pascual
NPNatalia Polanco
Natalia Polanco
MFMaría Dolores Folgueira
María Dolores Folgueira

18 August 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
IMIrene Muñoz-Gallego
Irene Muñoz-Gallego
MCMaría Ángeles Meléndez Carmona
María Ángeles Meléndez Carmona
Jaime Lora-TamayoJaime Lora-Tamayo
Jaime Lora-Tamayo
CGCarlos Garrido-Allepuz
Carlos Garrido-Allepuz
FCFernando Chaves
Fernando Chaves
EVEsther Viedma
Esther Viedma
Background: Persistent and relapsing prosthetic joint infection (PJI) due to Staphylococcus aureus presents a clinical challenge. This study aimed to provide an extensive description of phenotypic and genomic changes that could be related to persistence or relapse. Methods: Initial and second S. aureus isolates from 6 cases of persistent and relapsing PJI, along with clinical isolates from 8 cases, with favorable outcome were included. All isolates were studied by phenotypic and genotypic approaches. Results: Recurrent S. aureus isolates exhibited a significant increase in adhesive capacity, invasion and persistence compared to resolved isolates. No association was found for the presence or absence of certain genes with the persistence or relapse of PJI. All sequential isolates showed identical sequence type (ST). Resistance gene loss during the infection and a great diversity of variants in different virulence genes between the pair of strains, mainly in genes encoding adhesins such as fnbA, were observed. Conclusions: S. aureus-caused relapse and persistence PJI is associated with bacterial phenotypical and genotypical adaptation. The main paths of adaptation were persistence in the intracellular compartment, and the loss of antibiotic resistance genes and variant acquisition, especially in genes encoding adhesins.

8 July 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IMIrene Muñoz-Gallego
Irene Muñoz-Gallego
MCMaría Ángeles Meléndez Carmona
María Ángeles Meléndez Carmona
CHCarmen Martín Higuera
Carmen Martín Higuera
EVEsther Viedma
Esther Viedma
RDRafael Delgado
Rafael Delgado
MFMaría Dolores Folgueira
María Dolores Folgueira
The utility of reverse transcription-polymerase chain reaction (RT-PCR) in analysis SARS-COV-2 variants was evaluated. RT-PCR tests were used to analyse the majority of new SARS-CoV-2 cases (n = 9315) in a tertiary hospital (Madrid, Spain) throughout 2021. Subsequently, whole genome sequencing (WGS) was conducted on 10.8% of these samples (n = 1002). Notably, the Delta and Omicron variants emerged rapidly. There were no discrepancies between RT-PCR and WGS results. Continuous surveillance of SARS-CoV-2 variants is essential, and RT-PCR is a highly useful method, specially during periods of high COVID-19 incidence. This feasible technique can be implemented in all SARS-CoV-2 laboratories. However, WGS remains the gold standard method for comprehensive detection of all existing SARS-CoV-2 variants.

19 September 2022 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
PDF file
MCMaría Ángeles Meléndez Carmona
María Ángeles Meléndez Carmona
MMMikel Mancheño-Losa
Mikel Mancheño-Losa
ARAlbert Ruiz-Sorribas
Albert Ruiz-Sorribas
IMIrene Muñoz-Gallego
Irene Muñoz-Gallego
EVEsther Viedma
Esther Viedma
Jaime Lora-TamayoJaime Lora-Tamayo
Jaime Lora-Tamayo
Levofloxacin and rifampicin are the preferred treatment for prosthetic joint infection (PJI) caused by Staphylococcus aureus, especially when managed with implant retention (DAIR). However, a significant variability of success has been reported, which could be related to intrinsic characteristics of the microorganism. Our aim was to evaluate the variability in the anti-biofilm response to levofloxacin and rifampicin in a clinical collection of S. aureus. Eleven levofloxacin- and rifampicin-susceptible S. aureus isolates causing PJI managed with DAIR were included. Levofloxacin, rifampicin and levofloxacin + rifampicin were tested in an in vitro static biofilm model in microtitre plates, where 48 h biofilms were challenged with antimicrobials during 24 h. Additionally, two genetically similar strains were tested in the CDC Biofilm Reactor, where 48 h biofilms were treated during 56 h. Antimicrobial activity was assessed by viable biofilm-embedded cells recount, and by crystal violet staining. All antimicrobial regimens showed significant anti-biofilm activity, but a notable scattering in the response was observed across all strains (inter-strain coefficient of variation for levofloxacin, rifampicin and levofloxacin + rifampicin of 22.8%, 35.8% and 34.5%, respectively). This variability was tempered with the combination regimen when tested in the biofilm reactor. No correlation was observed between the minimal biofilm eradicative concentration and the antimicrobial activity. Recurrent S. aureus isolates exhibited higher biofilm-forming ability compared with strains from resolved infections (7.6 log10 cfu/cm2±0.50 versus 9.0 log10 cfu±0.07). Significant variability may be expected in response to levofloxacin and rifampicin among biofilm-embedded S. aureus. A response in the lower range, together with other factors of bad prognosis, could be responsible of treatment failure.